PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
17.51%
Net income growth under 50% of ORCL's 72.46%. Michael Burry would suspect deeper structural issues in generating bottom-line growth.
42.91%
D&A growth well above ORCL's 10.60%. Michael Burry would suspect heavier depreciation burdens that might erode net income unless top-line follows suit.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
339.63%
Well above ORCL's 443.64% if positive yoy. Michael Burry would see a risk of bigger working capital demands vs. competitor, harming free cash flow.
No Data
No Data available this quarter, please select a different quarter.
-300.00%
Negative yoy inventory while ORCL is 0.00%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
No Data
No Data available this quarter, please select a different quarter.
491.57%
Growth well above ORCL's 443.64%. Michael Burry would see a potential hidden liquidity or overhead issue overshadowing competitor's approach.
No Data
No Data available this quarter, please select a different quarter.
87.82%
Operating cash flow growth similar to ORCL's 89.66%. Walter Schloss would see parallel improvements or market conditions in cash generation.
-12.77%
Negative yoy CapEx while ORCL is 156.16%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
No Data
No Data available this quarter, please select a different quarter.
72.07%
Purchases growth of 72.07% while ORCL is zero at 0.00%. Bruce Berkowitz sees a mild difference in portfolio building that might matter for returns.
No Data
No Data available this quarter, please select a different quarter.
-802.94%
Both yoy lines negative, with ORCL at -211.01%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
34.26%
We have mild expansions while ORCL is negative at -63.74%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
No Data
No Data available this quarter, please select a different quarter.
-67.25%
Negative yoy issuance while ORCL is 150.00%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
-215.08%
We cut yoy buybacks while ORCL is 0.00%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.